Bladder Cancer Oncology Treatment
Discover Appleglc.com’s bladder cancer treatment library featuring enfortumab vedotin, erdafitinib, BCG immunotherapy, and checkpoint inhibitors for muscle-invasive and advanced disease.
Padcev
Enfortumab Vedotin
Opdivo
Nivolumab
Keytruda
Pembrolizumab
Imfinzi
Durvalumab
Imjudo
Tremelimumab-actl
Avzivi
Bevacizumab-tnjn
Balversa
Erdafitinib
Erdafitinib Injection
Erdafitinib
Yervoy
Ipilimumab
Trodelvy
Sacituzumab Govitecan-hziy
Bavencio
Avelumab
Mitomycin Intravesical
Mitomycin
Libtayo
Cemiplimab-rwlc
Zirabev
Bevacizumab-bvzr
Alymsys
Bevacizumab-maly
Mvasi
Bevacizumab-awwb
Platinol
Cisplatin
Gemzar
Gemcitabine Hydrochloride
Taxol
Paclitaxel
Abraxane
Paclitaxel Protein-Bound Particles
Nivolumab IV
Nivolumab
Nivolumab SC
Nivolumab and Hyaluronidase-nvhy
Pemfexy
Pemetrexed
Onxol
Paclitaxel
Paraplatin
Carboplatin
Eloxatin
Oxaliplatin
Xeloda
Capecitabine
Camptosar
Irinotecan Hydrochloride
Taxotere
Docetaxel
Velban
Vinblastine Sulfate
Ifex
Ifosfamide
Adriamycin
Doxorubicin Hydrochloride
BCG (Theracys)
Bacillus Calmette-Guérin
BCG (Tice)
Bacillus Calmette-Guérin Live
Mitomycin C
Mitomycin
Trodelvy IV
Sacituzumab Govitecan-hziy
Pembrolizumab IV
Pembrolizumab
Vyxeos
Daunorubicin/Cytarabine Liposome
Tecentriq
Atezolizumab
Tepmetko
Tepotinib